DE:51S Stock Latest News
Company AnnouncementsCynata Completes Share Issue to Support Expanding Stem Cell Pipeline2d ago
Company AnnouncementsCynata Seeks ASX Quotation for 2 Million New Shares2d ago
Company AnnouncementsCynata Engages Director as Consultant to Drive Asset Strategy2d ago
Company AnnouncementsCynata shores up balance sheet with fully underwritten entitlement offer2d ago
Company AnnouncementsCynata Slashes Costs and Raises Capital to Extend Cash Runway to 20285d ago
Company AnnouncementsCynata moves 2026 AGM to in-person format with digital-first shareholder communications1w agoCompany AnnouncementsCynata Director Paul Wotton to Exit Board as Company Enters New Strategic Phase1w ago
Company AnnouncementsCynata Offers Fee-Free Exit for Small Shareholders via Unmarketable Parcel Facility1w ago
Company AnnouncementsCynata Sets Target Market for New Share Options in Revised Prospectus2w ago
Company AnnouncementsCynata Launches Fully Underwritten Entitlement Offer via Replacement Prospectus2w ago
Company AnnouncementsCynata defines target market for new options in capital raising3w ago
Company AnnouncementsCynata Therapeutics Launches Renounceable Entitlement Offer to Raise Capital3w ago
Company AnnouncementsCynata Plans Issue of 18 Million Options to Support Capital Needs3w ago
Company AnnouncementsCynata Ends Equity Facility With Acuity, Plans Buyback of Security Shares3w ago- Company AnnouncementsCynata Uses $1.7m R&D Refund to Clear Loan and Bolster Cymerus Strategy3w ago
Company AnnouncementsCynata Extends R&D Tax Incentive Loan Ahead of $1.7m Rebate1M ago- Company AnnouncementsCynata Updates Corporate Governance Framework to Strengthen Board Oversight1M ago
Company AnnouncementsCynata Releases 2025/2026 Annual Report and Confirms Corporate Structure1M ago